AF
KURA icon

Allworth Financial’s Kura Oncology KURA Stock Holding History

Allworth Financial’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$113K Buy
10,326
+6,169
+148% +$58.2K ﹤0.01% 1865
2026
Q1 		$33.8K Buy
4,157
+11
+0.3% +$94 ﹤0.01% 2612
2025
Q4 		$43.1K Buy
4,146
+1,553
+60% +$16.3K ﹤0.01% 2298
2025
Q3 		$22.9K Buy
2,593
+1,615
+165% +$11.5K ﹤0.01% 2618
2025
Q2 		$5.64K Buy
978
+469
+92% +$2.87K ﹤0.01% 3198
2025
Q1 		$3.27K Buy
509
+321
+171% +$2.5K ﹤0.01% 3001
2024
Q4 		$1.48K Buy
188
+178
+1,780% +$2.56K ﹤0.01% 3265
2024
Q3 		$196 Sell
10
-48
-83% -$973 ﹤0.01% 3598
2024
Q2 		$1.22K Buy
58
+9
+18% +$185 ﹤0.01% 3102
2024
Q1 		$1.05K Hold
49
– – ﹤0.01% 3063
2023
Q4 		$705 Buy
+49
New +$482 ﹤0.01% 3055
2023
Q3 		– Sell
-23
Closed -$244 – 3492
2023
Q2 		$244 Buy
+23
New +$272 ﹤0.01% 3056
2022
Q3 		– Sell
-8
Closed – – 2889
2022
Q2 		$0 Buy
+8
New +$115 ﹤0.01% 2606

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Allworth Financial's KURA Position: Q2 2026 in Review

Allworth Financial increased its Kura Oncology (KURA) stake by 148% in Q2 2026, buying an estimated $58.2K and bringing the position to 10,326 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #1865.

Allworth Financial first reported a position in KURA in Q2 2022 and has held it in 13 quarters since. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Allworth Financial held 10,326 shares of Kura Oncology worth $113K as of Q2 2026.
  • Allworth Financial bought 6,169 Kura Oncology shares in Q2 2026, an estimated $58.2K.
  • Kura Oncology made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #1865 holding.
  • Allworth Financial first reported a position in Kura Oncology in Q2 2022 and has held it in 13 quarters since.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.